Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Murray Fershtman

Pediatrics Conroe, TX Medical Doctor

NPI 1013093897 CMS profile 227142

3115 College Park Dr, Ste #104, Conroe, TX 77384

Open in the dashboard

General payments

$3,923

205 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Murray Fershtman of Conroe, TX is reported in the CMS Open Payments database as having received $3,923 across 205 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $366 15
2024 General $688 40
2023 General $664 40
2022 General $535 31
2021 General $1,103 49
2020 General $165 10
2019 General $403 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Murray Fershtman
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Murray Fershtman were reported at $366. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Murray Fershtman Pediatrics median Middle half National median
2019 $403 $86 $31–$183 $163
2020 $165 $49 $22–$110 $114
2021 $1,103 $68 $27–$158 $132
2022 $535 $77 $30–$173 $149
2023 $664 $88 $33–$190 $160
2024 $688 $94 $34–$206 $164
2025 $366 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $640 26 payments
  2. Corium, Inc. $524 24 payments
  3. Ironshore Pharmaceuticals Inc. $457 32 payments
  4. Supernus Pharmaceuticals, Inc. $430 18 payments
  5. Cranial Technologies, Inc $355 23 payments
  6. Merck Sharp & Dohme Corporation $319 19 payments
  7. Pfizer Inc. $313 11 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $251 17 payments
  9. Sanofi Pasteur Inc. $250 12 payments
  10. Neos Therapeutics, LP $86 6 payments
  11. Other $297 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,906 203 payments
  2. Education $17 2 payments
Products named General payments · program years 2019–2025
  1. Azstarys $524 24 payments
  2. JORNAY PM $407 29 payments
  3. Dyanavel XR $379 15 payments
  4. Doc Band $355 23 payments
  5. QELBREE $336 12 payments
  6. GARDASIL 9 $294 17 payments
  7. VYVANSE $277 19 payments
  8. VAXELIS $267 15 payments
  9. TRUMENBA $216 6 payments
  10. VAXNEUVANCE $205 11 payments
  11. Other $2,035 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

205 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record